OptimizeRx Corp - Director's Dealing 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OptimizeRx Corp (OPRX)
CIK: 0001448431
Period of Report: 2017-02-06

Reporting Person: Vos Ellen O'Connor (Director)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-02-06	Common Stock	P	1000	$0.77	Acquired	1000	Indirect
2017-02-08	Common Stock	P	1000	$0.76	Acquired	2000	Indirect
2017-02-08	Common Stock	P	1000	$0.73	Acquired	3000	Indirect
2017-02-09	Common Stock	P	2000	$0.75	Acquired	5000	Indirect
2017-02-10	Common Stock	P	2000	$0.70	Acquired	7000	Indirect
2017-02-15	Common Stock	P	1000	$0.77	Acquired	8000	Indirect
2017-02-21	Common Stock	P	1000	$0.75	Acquired	9000	Indirect
2017-02-28	Common Stock	P	1000	$0.71	Acquired	10000	Indirect
2017-03-01	Common Stock	P	1000	$0.70	Acquired	11000	Indirect
2017-03-06	Common Stock	P	1000	$0.85	Acquired	12000	Indirect
2017-03-10	Common Stock	P	1000	$0.81	Acquired	13000	Indirect
2017-03-13	Common Stock	P	2000	$0.81	Acquired	15000	Indirect
2017-03-14	Common Stock	P	1000	$0.85	Acquired	16000	Indirect
2017-03-16	Common Stock	P	2000	$0.82	Acquired	18000	Indirect
2017-03-17	Common Stock	P	1000	$0.81	Acquired	19000	Indirect
2017-03-20	Common Stock	P	1000	$0.81	Acquired	20000	Indirect
2017-03-21	Common Stock	P	1000	$0.80	Acquired	21000	Indirect
2017-03-22	Common Stock	P	2000	$0.81	Acquired	23000	Indirect
2017-03-23	Common Stock	P	1000	$0.81	Acquired	24000	Indirect
2017-03-24	Common Stock	P	1000	$0.81	Acquired	25000	Indirect
2017-04-12	Common Stock	P	2000	$0.74	Acquired	27000	Indirect
2017-05-03	Common Stock	P	1000	$0.75	Acquired	28000	Indirect